This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mesnil, M. Articles by Yamasaki, H. Search for Related Content PubMed PubMed Citation Articles by Mesnil, M. Articles by Yamasaki, H.

Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular Communication¹

Unit of Multistage Carcinogenesis, IARC, F-69372, Lyon cedex 08, France

Antitumor suicide gene therapy is one of the emerging strategies against cancer. It consists of the introduction into cancer cells of a gene capable of converting a nontoxic prodrug into a cytotoxic drug. Because this therapeutic gene cannot be easily introduced into the whole cell population of a tumor, the successful eradication of tumors depends on a phenomenon called the "bystander effect," by which the introduced gene can affect even cells in which it is not itself present. From a therapeutic point of view, it may be crucial to enhance this phenomenon through various means to achieve tumor eradication. One such suicide gene, the thymidine kinase gene from the herpes simplex virus, in combination with the prodrug ganciclovir, has been extensively and successfully used in some animal models exhibiting a strong bystander effect. Among the mechanisms involved in this phenomenon, gap junctional intercellular communication (GJIC) is directly involved in the transfer of the toxic metabolites of ganciclovir, which pass directly from herpes simplex virus thymidine kinase-expressing cells to surrounding cells that do not express it. Because GJIC appears to be a mediator of the bystander effect both in vitro and in vivo, here we review possible molecular strategies for enhancing the extent of tumor cell death by increasing the intratumoral GJIC capacity.

This article has been cited by other articles:

				S. P. Kalva, A. Thabet, and S. Wicky Recent Advances in Transarterial Therapy of Primary and Secondary Liver Malignancies RadioGraphics, January 1, 2008; 28(1): 101 - 117. [Abstract] [Full Text] [PDF]

				W.-P. Deng, C.-C. Wu, C.-C. Lee, W. K. Yang, H.-E. Wang, R.-S. Liu, H.-J. Wei, J. G. Gelovani, J.-J. Hwang, D.-M. Yang, et al. Serial In Vivo Imaging of the Lung Metastases Model and Gene Therapy Using HSV1-tk and Ganciclovir J. Nucl. Med., May 1, 2006; 47(5): 877 - 884. [Abstract] [Full Text] [PDF]

				B. G. Gentry, P. D. Boucher, and D. S. Shewach Hydroxyurea Induces Bystander Cytotoxicity in Cocultures of Herpes Simplex Virus Thymidine Kinase-Expressing and Nonexpressing HeLa Cells Incubated with Ganciclovir. Cancer Res., April 1, 2006; 66(7): 3845 - 3851. [Abstract] [Full Text] [PDF]

				P. D. Boucher, M. M. Im, S. O. Freytag, and D. S. Shewach A novel mechanism of synergistic cytotoxicity with 5-fluorocytosine and ganciclovir in double suicide gene therapy. Cancer Res., March 15, 2006; 66(6): 3230 - 3237. [Abstract] [Full Text] [PDF]

				C. Shao, M. Folkard, B. D. Michael, and K. M. Prise Targeted cytoplasmic irradiation induces bystander responses PNAS, September 14, 2004; 101(37): 13495 - 13500. [Abstract] [Full Text] [PDF]

				M. Maemondo, Y. Saijo, K. Narumi, T. Kikuchi, K. Usui, R. Tazawa, K. Matsumoto, T. Nakamura, K. Sasaki, M. Takahashi, et al. Gene Therapy with Secretory Leukoprotease Inhibitor Promoter-Controlled Replication-Competent Adenovirus for Non-Small Cell Lung Cancer Cancer Res., July 1, 2004; 64(13): 4611 - 4620. [Abstract] [Full Text] [PDF]

				R. Thust, M.T. Tomicic, R. Grabner, C. Friedrichs, P. Wutzler, and B. Kaina Cytogenetic detection of a trans-species bystander effect: induction of sister chromatid exchanges in murine 3T3 cells by ganciclovir metabolized in HSV thymidine kinase gene-transfected Chinese hamster ovary cells Mutagenesis, January 1, 2004; 19(1): 27 - 33. [Abstract] [Full Text] [PDF]

				K. Chamoto, T. Tsuji, H. Funamoto, A. Kosaka, J. Matsuzaki, T. Sato, H. Abe, K. Fujio, K. Yamamoto, T. Kitamura, et al. Potentiation of Tumor Eradication by Adoptive Immunotherapy with T-cell Receptor Gene-Transduced T-Helper Type 1 Cells Cancer Res., January 1, 2004; 64(1): 386 - 390. [Abstract] [Full Text] [PDF]

				E. I. Azzam, S. M. de Toledo, and J. B. Little Expression of CONNEXIN43 Is Highly Sensitive to Ionizing Radiation and Other Environmental Stresses Cancer Res., November 1, 2003; 63(21): 7128 - 7135. [Abstract] [Full Text] [PDF]

				J.-H. Yang, S. F. Basinger, R. L. Gross, and S. M. Wu Blue Light-Induced Generation of Reactive Oxygen Species in Photoreceptor Ellipsoids Requires Mitochondrial Electron Transport Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1312 - 1319. [Abstract] [Full Text] [PDF]

				M. Adachi, J. Sampath, L.-b. Lan, D. Sun, P. Hargrove, R. Flatley, A. Tatum, M. Z. Edwards, M. Wezeman, L. Matherly, et al. Expression of MRP4 Confers Resistance to Ganciclovir and Compromises Bystander Cell Killing J. Biol. Chem., October 4, 2002; 277(41): 38998 - 39004. [Abstract] [Full Text] [PDF]

				L.-O. Klotz, P. Patak, N. Ale-Agha, D. P. Buchczyk, K. Abdelmohsen, P. A. Gerber, C. von Montfort, and H. Sies 2-Methyl-1,4-naphthoquinone, Vitamin K3, Decreases Gap-Junctional Intercellular Communication via Activation of the Epidermal Growth Factor Receptor/Extracellular Signal-regulated Kinase Cascade Cancer Res., September 1, 2002; 62(17): 4922 - 4928. [Abstract] [Full Text] [PDF]

				W. R. Wilson, S. M. Pullen, A. Hogg, N. A. Helsby, K. O. Hicks, and W. A. Denny Quantitation of Bystander Effects in Nitroreductase Suicide Gene Therapy Using Three-Dimensional Cell Cultures Cancer Res., March 1, 2002; 62(5): 1425 - 1432. [Abstract] [Full Text] [PDF]

				M. C. Luna, X. Chen, S. Wong, J. Tsui, N. Rucker, A. S. Lee, and C. J. Gomer Enhanced Photodynamic Therapy Efficacy with Inducible Suicide Gene Therapy Controlled by the grp Promoter Cancer Res., March 1, 2002; 62(5): 1458 - 1461. [Abstract] [Full Text] [PDF]

				M. P. Piechocki, F. Lonardo, J. F. Ensley, T. Nguyen, H. Kim, and G. H. Yoo Anticancer Activity of Docetaxel in Murine Salivary Gland Carcinoma Clin. Cancer Res., March 1, 2002; 8(3): 870 - 877. [Abstract] [Full Text] [PDF]

				J. L. Carroll, L. L. Nielsen, S. B. Pruett, and J. M. Mathis The Role of Natural Killer Cells in Adenovirus-mediated p53 Gene Therapy Mol. Cancer Ther., November 1, 2001; 1(1): 49 - 60. [Abstract] [Full Text] [PDF]

				C. F. Brosnan, E. Scemes, and D. C. Spray Cytokine Regulation of Gap Junction Connectivity : An Open-and-Shut Case or Changing Partners at the Nexus? Am. J. Pathol., May 1, 2001; 158(5): 1565 - 1569. [Full Text] [PDF]

				T. Ichikawa, W. P. Petros, S. M. Ludeman, J. Fangmeier, F. H. Hochberg, O. M. Colvin, and E. A. Chiocca Intraneoplastic Polymer-based Delivery of Cyclophosphamide for Intratumoral Bioconversion by a Replicating Oncolytic Viral Vector Cancer Res., February 1, 2001; 61(3): 864 - 868. [Abstract] [Full Text]